Similarly, in AD, inflammation-related signaling pathways, including the NF-κB pathway, the complement system, and pro-inflammatory factors are activated, and the concentrations of inflammatory factors in the tissues and body fluids of the body of AD patients are significantly elevated [4, 185]. Here, NFKB1 is linked to Alzheimer disease.